Intervention
biologic sample preservation procedure
ClinicalTrials.gov intervention label
Clinical trials
16 shownCollecting and Storing Tissue Samples From Women With or Without Breast CancerNCT00899301 · 2004-01-22
RECRUITINGMolecular Predictors of Cancer in Patients at High Risk of Lung CancerNCT00898313 · 2003-12-01
RECRUITINGCollecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung CancerNCT00897117 · 2001-05-01
RECRUITINGCorrelation of Molecular Markers With Response to Therapy and Breast Cancer BehaviorNCT01000883 · 1998-12-01
RECRUITINGCollecting and Studying Tissue Samples From Patients With HIV-Associated MalignanciesNCT01567722 · 2013-01-02
TERMINATEDMRI in Diagnosing Prostate CancerNCT01292291 · 2011-04-01
UNKNOWNBone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3NCT00688246 · 2008-07-10
COMPLETEDLaser Spectroscopy of Breast Tissue Through a Needle DeviceNCT00918788 · 2008-04-01
COMPLETEDMolecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy ParticipantsNCT00899457 · 2008-04-01
COMPLETEDSkin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid TumorsNCT00369109 · 2006-02-01
COMPLETEDStudying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) RegionNCT00693836 · 2006-01-01
UNKNOWNSerum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE)NCT00898209 · 2003-04-01
TERMINATEDStudy of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate CancerNCT00967889 · 2002-01-01
UNKNOWNBlood Sample Collection and Health Information Collection From Patients With Invasive Breast Cancer and Their Brothers and SistersNCT00445562 · 2001-01-01
UNKNOWNS9925: Collecting and Storing Samples From Patients With Lung CancerNCT00920010 · 2000-09-01
COMPLETEDStudying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45NCT00914043
WITHDRAWNCommon conditions
Leading sponsors
Vanderbilt-Ingram Cancer Center5AIDS Malignancy Consortium1Barbara Ann Karmanos Cancer Institute1Cancer Research Centre at Weston Park Hospital1Cancer Research UK1Case Comprehensive Cancer Center1GenBasix Incorporated1NCIC Clinical Trials Group1NSABP Foundation Inc1SWOG Cancer Research Network1UNC Lineberger Comprehensive Cancer Center1University College London Hospitals1
Trial status mix
COMPLETED5
RECRUITING4
UNKNOWN4
TERMINATED2
WITHDRAWN1
Phase mix
NA1
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.